Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05471518 · ClinicalTrials.gov registry record
Sex Hormone and Vascular Function in Women With CKD
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 51
- Enrollment target
NCT05471518 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 51 participants.
The verdict
NCT05471518 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The risk of cardiovascular disease (CVD) is significantly elevated in patients with chronic kidney disease (CKD). Notably, women with CKD commonly experience menstrual disturbances induced by CKD, which may contribute to impaired vascular function and elevated CVD risk. However, most of the literature in the field of nephrology focuses on male patients, and studies on women's vascular health are limited. Moreover, endogenous sex hormones, particularly estradiol, are well-documented to be cardioprotective in women without CKD; however, the role of sex hormones on vascular function in women with CKD remains unclear. The goals of the proposed project are: 1) to evaluate vasuclar function in pre- and post-menopausal women with CKD vs. age-matched healthy women; 2) to evaluate sex hormone concentrations and determine whether they associate with vascular function in the proposed cohort; and 3) to gain mechanistic insight on the association between sex hormones and vascular dysfunction in the proposed cohort.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2024-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05471518
The ClinicalTrials.gov registry entry for NCT05471518 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT05471518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05471518 about?
NCT05471518 is a clinical study titled "Sex Hormone and Vascular Function in Women With CKD". The risk of cardiovascular disease (CVD) is significantly elevated in patients with chronic kidney disease (CKD). Notably, women with CKD commonly experience menstrual disturbances induced by CKD, which may contribute to impaired vascular function and elevated CVD risk. However, most of the literatu...
What is the current status of trial NCT05471518?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2021-07-01. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT05471518?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05471518?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.